Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1993 Dec;52(12):866–869. doi: 10.1136/ard.52.12.866

Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis.

M Hakala 1, L Risteli 1, J Manelius 1, P Nieminen 1, J Risteli 1
PMCID: PMC1005217  PMID: 8311537

Abstract

OBJECTIVES--To assess the extent and clinical significance of type I collagen degradation in rheumatoid arthritis (RA). METHODS--Serum samples from 90 consecutive patients with RA from a cross-sectional population based study and 90 age- and sex-matched controls were analysed with the new assay of cross-linked carboxyterminal telopeptide of type I collagen (ICTP). RESULTS--Patients with RA had significantly higher concentrations of ICTP than the controls. ICTP correlated strongly with measures of impairment in RA, such as the erosive state of joint disease (ES) (r = 0.57, p < 0.001) and Keitel function test (KFT) (r = 0.49, p < 0.001), and more weakly with various disease activity markers. When erythrocyte sedimentation rate (ESR), ES or KFT were used as indicators of disease severity among the patients with disease duration over five years, ICTP distinguished the more serious RA from milder cases. CONCLUSIONS--Elevated serum concentrations of ICTP are common in RA and are associated with signs of aggressive disease.

Full text

PDF
866

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arend W. P., Dayer J. M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum. 1990 Mar;33(3):305–315. doi: 10.1002/art.1780330302. [DOI] [PubMed] [Google Scholar]
  2. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  3. Brower A. C. Use of the radiograph to measure the course of rheumatoid arthritis. The gold standard versus fool's gold. Arthritis Rheum. 1990 Mar;33(3):316–324. doi: 10.1002/art.1780330303. [DOI] [PubMed] [Google Scholar]
  4. Eberl D. R., Fasching V., Rahlfs V., Schleyer I., Wolf R. Repeatability and objectivity of various measurements in rheumatoid arthritis. A comparative study. Arthritis Rheum. 1976 Nov-Dec;19(6):1278–1286. doi: 10.1002/art.1780190608. [DOI] [PubMed] [Google Scholar]
  5. Elomaa I., Virkkunen P., Risteli L., Risteli J. Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma. Br J Cancer. 1992 Aug;66(2):337–341. doi: 10.1038/bjc.1992.266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Eriksen E. F., Charles P., Melsen F., Mosekilde L., Risteli L., Risteli J. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res. 1993 Feb;8(2):127–132. doi: 10.1002/jbmr.5650080202. [DOI] [PubMed] [Google Scholar]
  7. Gabriel S. E., Luthra H. S. Rheumatoid arthritis: can the long-term outcome be altered? Mayo Clin Proc. 1988 Jan;63(1):58–68. doi: 10.1016/s0025-6196(12)62665-2. [DOI] [PubMed] [Google Scholar]
  8. Hakala M., Pöllänen R., Nieminen P. The ARA 1987 revised criteria select patients with clinical rheumatoid arthritis from a population based cohort of subjects with chronic rheumatic diseases registered for drug reimbursement. J Rheumatol. 1993 Oct;20(10):1674–1678. [PubMed] [Google Scholar]
  9. Hancock D. A., Asiedu-Offei S., Atkinson P. J., Reed G. W., Wright V. Femoral bone mass in patients with rheumatoid arthritis and osteoarthrosis. Rheumatol Rehabil. 1978 May;17(2):65–71. doi: 10.1093/rheumatology/17.2.65. [DOI] [PubMed] [Google Scholar]
  10. Keitel W., Hoffmann H., Weber G., Krieger U. Ermittlung der prozentualen Funktionsminderung der Gelenke durch einen Bewegungsfunktionstest in der Rheumatologie. Dtsch Gesundheitsw. 1971 Oct 1;26(40):1901–1903. [PubMed] [Google Scholar]
  11. Kushner I. C-reactive protein in rheumatology. Arthritis Rheum. 1991 Aug;34(8):1065–1068. doi: 10.1002/art.1780340819. [DOI] [PubMed] [Google Scholar]
  12. Larsen A., Dale K., Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh) 1977 Jul;18(4):481–491. doi: 10.1177/028418517701800415. [DOI] [PubMed] [Google Scholar]
  13. Luukkainen R. Chrysotherapy in rheumatoid arthritis with particular emphasis on the effect of chrysotherapy on radiographical changes and on the optimal time of initiation of therapy. Scand J Rheumatol Suppl. 1980;34:1–56. [PubMed] [Google Scholar]
  14. McCarthy C. K., Steinberg G. G., Agren M., Leahey D., Wyman E., Baran D. T. Quantifying bone loss from the proximal femur after total hip arthroplasty. J Bone Joint Surg Br. 1991 Sep;73(5):774–778. doi: 10.1302/0301-620X.73B5.1894664. [DOI] [PubMed] [Google Scholar]
  15. Peel N., Eastell R., Russell G. Markers of bone and collagen breakdown in early inflammatory arthritis. Baillieres Clin Rheumatol. 1992 Jun;6(2):351–372. doi: 10.1016/s0950-3579(05)80179-7. [DOI] [PubMed] [Google Scholar]
  16. Risteli J., Elomaa I., Niemi S., Novamo A., Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem. 1993 Apr;39(4):635–640. [PubMed] [Google Scholar]
  17. Ritchie D. M., Boyle J. A., McInnes J. M., Jasani M. K., Dalakos T. G., Grieveson P., Buchanan W. W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med. 1968 Jul;37(147):393–406. [PubMed] [Google Scholar]
  18. Roodman G. D. Interleukin-6: an osteotropic factor? J Bone Miner Res. 1992 May;7(5):475–478. doi: 10.1002/jbmr.5650070502. [DOI] [PubMed] [Google Scholar]
  19. Seibel M. J., Duncan A., Robins S. P. Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases. J Rheumatol. 1989 Jul;16(7):964–970. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES